Insmed (INSM) Retained Earnings (2010 - 2026)
Insmed (INSM) recorded quarterly Retained Earnings of -$5.8 billion in Q1 2026, down 397105.82% quarter-over-quarter from $1.5 million in Q4 2025, and down 25.64% on a YoY basis from -$7.8 billion in Q1 2025.
Insmed (INSM) Retained Earnings (2010 - 2026) Analysis & Trends
Insmed's Retained Earnings history runs 17 years deep, the most recent figure standing at -$5.8 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 25.64% year-over-year to -$5.8 billion; the TTM figure through Mar 2026 stood at -$5.8 billion (down 25.64% YoY), while the FY2025 annual figure was $1.5 million, up 163.83% from the prior year.
- Retained Earnings was -$5.8 billion for Q1 2026 at Insmed, down from $1.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.7 million in Q2 2025 to a low of -$5.8 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$2.0 billion across 5 years, with a median of -$2.5 billion in 2022.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 2536555.0% in 2022, then surged 163.83% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$2.7 billion in 2022, then declined by 27.8% to -$3.4 billion in 2023, then surged by 99.93% to -$2.3 million in 2024, then soared by 163.83% to $1.5 million in 2025, then plunged by 397105.82% to -$5.8 billion in 2026.
- The last three Retained Earnings figures came in at -$5.8 billion (Q1 2026), $1.5 million (Q4 2025), and -$5.3 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -5.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.80 Bn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | -5.31 Bn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | -4.62 Bn |
| Dec 31, 2024 | -2.29 Mn |
| Sep 30, 2024 | -4.12 Bn |
| Jun 30, 2024 | -2.83 Mn |
| Mar 31, 2024 | -1.64 Mn |
| Dec 31, 2023 | -3.45 Bn |
| Sep 30, 2023 | -3.26 Bn |
| Jun 30, 2023 | -1.25 Mn |
| Mar 31, 2023 | -2.86 Bn |
| Dec 31, 2022 | -2.70 Bn |
| Sep 30, 2022 | -2.54 Bn |
| Jun 30, 2022 | -929,000.00 |
| Mar 31, 2022 | -230,000.00 |
| Dec 31, 2021 | -2.27 Bn |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 424,000.00 |